MC

453.45

-2.24%↓

SANES

6.794

-2.31%↓

BNP

74.71

-2.25%↓

ALV

333.4

-1.51%↓

BBVA

12.865

-1.57%↓

MC

453.45

-2.24%↓

SANES

6.794

-2.31%↓

BNP

74.71

-2.25%↓

ALV

333.4

-1.51%↓

BBVA

12.865

-1.57%↓

MC

453.45

-2.24%↓

SANES

6.794

-2.31%↓

BNP

74.71

-2.25%↓

ALV

333.4

-1.51%↓

BBVA

12.865

-1.57%↓

MC

453.45

-2.24%↓

SANES

6.794

-2.31%↓

BNP

74.71

-2.25%↓

ALV

333.4

-1.51%↓

BBVA

12.865

-1.57%↓

MC

453.45

-2.24%↓

SANES

6.794

-2.31%↓

BNP

74.71

-2.25%↓

ALV

333.4

-1.51%↓

BBVA

12.865

-1.57%↓

Search

AB Science SA

Closed

1.14 0.18

Overview

Share price change

24h

Current

Min

1.122

Max

1.142

Key metrics

By Trading Economics

Income

-4.5M

Sales

560K

Profit margin

-798.036

Employees

28

EBITDA

-4.6M

Market Stats

By TradingEconomics

Market Cap

78M

Previous open

0.96

Previous close

1.14

Technical Score

By Trading Central

Confidence

Bearish Evidence

AB Science SA Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

18 cze 2025, 17:32 UTC

Major Market Movers

Lion Group Shares Climb on $600 Million Loan for Crypto Treasury

18 cze 2025, 23:55 UTC

Acquisitions, Mergers, Takeovers

Nippon Steel: To Book Restructuring Loss Related to This Sale in 1Q

18 cze 2025, 23:53 UTC

Acquisitions, Mergers, Takeovers

Nippon Steel: NS Kote Is an Entity That Owns All of Company's Equity Stake in AM/NS Calvert

18 cze 2025, 23:50 UTC

Acquisitions, Mergers, Takeovers

Nippon Steel: To Book About Y230B Loss Related to Sale of NS Kote to ArcelorMittal

18 cze 2025, 23:50 UTC

Market Talk

Australian Uranium Stocks Tipped to Go Higher -- Market Talk

18 cze 2025, 23:43 UTC

Market Talk

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

18 cze 2025, 23:43 UTC

Market Talk

Global Equities Roundup: Market Talk

18 cze 2025, 23:43 UTC

Market Talk

Nikkei May Decline Amid Middle East Uncertainty -- Market Talk

18 cze 2025, 23:07 UTC

Market Talk

Fletcher Building Recovery May Be More Muted Than Thought -- Market Talk

18 cze 2025, 23:00 UTC

Market Talk

Smart Glasses Seen as Possible Future Agentic AI Platform -- Market Talk

18 cze 2025, 21:50 UTC

Market Talk

Argentina Poised To Become Significant LNG Exporter, Rystad Says -- Market Talk

18 cze 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

18 cze 2025, 20:38 UTC

Acquisitions, Mergers, Takeovers

U.S. Steel and Nippon Finalize Their 'Partnership.' What Comes After the Merger. -- Barrons.com

18 cze 2025, 20:32 UTC

Earnings

These Stocks Moved the Most Today: Tesla, Marvell, Sunrun, Nucor, Circle Internet, Korn Ferry, GMS, and More -- Barrons.com

18 cze 2025, 19:59 UTC

Market Talk

Oil Edges Up as Next Steps in Iran Conflict Eyed -- Market Talk

18 cze 2025, 19:42 UTC

Market Talk

Natural Gas Extends Gains for Fourth Session -- Market Talk

18 cze 2025, 19:40 UTC

Earnings

Fed Holds Rates Steady and Keeps Door Open to Cuts -- 3rd Update

18 cze 2025, 18:47 UTC

Acquisitions, Mergers, Takeovers

Railroads Have Slashed Costs and Raised Prices. Why One CEO Now Favors a Merger. -- Barrons.com

18 cze 2025, 18:33 UTC

Market Talk

Fitch Says U.S. Fiscal Outlook Remains Challenging -- Market Talk

18 cze 2025, 18:26 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

18 cze 2025, 18:26 UTC

Market Talk

Nucor, Steel Dynamics Seen Diverging In Approach To Current Business Climate -- Market Talk

18 cze 2025, 18:15 UTC

Market Talk

Gold Stays Flat After Fed Decision -- Market Talk

18 cze 2025, 17:42 UTC

Acquisitions, Mergers, Takeovers

ArcelorMittal Expects Related 2Q Gain of About $1.5B

18 cze 2025, 17:40 UTC

Acquisitions, Mergers, Takeovers

ArcelorMittal Completes Acquisition of Nippon Steel's 50% Interest in AM/NS Calvert

18 cze 2025, 17:20 UTC

Earnings

Credit Card Annual Fees Are Going Up. What It Means for the Stocks. -- Barrons.com

18 cze 2025, 16:52 UTC

Market Talk

Trump Awakens Canada On Need For Fewer Trade Barriers, Macklem Says -- Market Talk

18 cze 2025, 16:31 UTC

Acquisitions, Mergers, Takeovers

Nippon Steel Completes Purchase of U.S. Steel After Reaching Security Deal With Trump Administration -- Update

18 cze 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

18 cze 2025, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

18 cze 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

Peer Comparison

Price change

AB Science SA Forecast

Technical Score

By Trading Central

1.426 / 1.448Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Bullish Evidence

Long Term

Bullish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About AB Science SA

AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and central nervous system, and cancers in France. The company's lead compound is the masitinib, a tyrosine kinase inhibitor which is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis, indolent systemic mastocytosis, severe asthma, progressive forms of multiple sclerosis, first line pancreatic cancer with pain, alzheimer's disease, and metastatic castrate-resistant prostate cancer, as well as in Phase II clinical trial to treat Covid-19. It also developing AB8939, a microtubule destabiliser for acute myeloid leukemia. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.